Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/ritonavir and lamivudine in naïve HIV-1 infection
NCT02770508Phase 4Completed
- Sponsor
- Fundación Huésped
- Start
- Nov 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir, ritonavir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Fundación Huésped. Started Nov 2015; status: completed.
02
Drugs
darunavirritonavirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02770508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770508.